Colgate-Palmolive Company $CL Shares Sold by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp lessened its stake in Colgate-Palmolive Company (NYSE:CL) by 0.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,683,240 shares of the company’s stock after selling 14,832 shares during the quarter. OMERS ADMINISTRATION Corp owned about 0.21% of Colgate-Palmolive worth $133,010,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Sienna Gestion acquired a new stake in Colgate-Palmolive during the fourth quarter worth $1,507,000. USS Investment Management Ltd increased its stake in Colgate-Palmolive by 26.8% during the fourth quarter. USS Investment Management Ltd now owns 2,146,622 shares of the company’s stock worth $169,637,000 after acquiring an additional 453,470 shares during the last quarter. Vanguard Personalized Indexing Management LLC increased its stake in Colgate-Palmolive by 22.0% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 111,164 shares of the company’s stock worth $8,784,000 after acquiring an additional 20,013 shares during the last quarter. Panagora Asset Management Inc. increased its stake in Colgate-Palmolive by 51.7% during the fourth quarter. Panagora Asset Management Inc. now owns 336,831 shares of the company’s stock worth $26,616,000 after acquiring an additional 114,789 shares during the last quarter. Finally, Resources Management Corp CT ADV increased its stake in Colgate-Palmolive by 209.1% during the fourth quarter. Resources Management Corp CT ADV now owns 8,606 shares of the company’s stock worth $680,000 after acquiring an additional 5,822 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.3%

CL opened at $90.59 on Tuesday. The business has a fifty day moving average price of $86.96 and a 200 day moving average price of $86.38. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The stock has a market capitalization of $72.49 billion, a price-to-earnings ratio of 35.25, a PEG ratio of 4.72 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.Colgate-Palmolive’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.91 EPS. Sell-side analysts expect that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is 82.49%.

Analysts Set New Price Targets

Several research firms have issued reports on CL. UBS Group raised their target price on Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. TD Cowen reissued a “hold” rating and set a $85.00 target price on shares of Colgate-Palmolive in a research note on Tuesday, March 31st. JPMorgan Chase & Co. raised their target price on Colgate-Palmolive from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, May 4th. Wells Fargo & Company cut their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 8th. Finally, Barclays raised their target price on Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 5th. Twelve research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.